Abstract
In this work, two oximes for the treatment of tabun-inhibited acetylcholinesterase (AChE; EC 3.1.1.7), K074 (1,4-bis(4-hydroxyiminomethylpyridinium)butane dibromide) and K075 ((E)-1,4-bis(4-hydroxyiminomethylpyridinium)but-2-en dibromide), were tested in vitro as reactivators of AChE. Comparison was made with currently used AChE reactivators (pralidoxime, HI-6, methoxime and obidoxime). Human brain homogenate was taken as an appropriate source of the cholinesterases. As resulted, oxime K074 appears to be the most potent reactivator of tabun-inhibited AChE, with reactivation potency comparable to that of obidoxime. A second AChE reactivator, K075, does not attain as great a reactivation potency as K074, although its maximal reactivation (17%) was achieved at relevant concentrations for humans.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcholinesterase / metabolism*
-
Butanes / chemistry
-
Butanes / pharmacology*
-
Caudate Nucleus / drug effects
-
Caudate Nucleus / enzymology*
-
Cholinesterase Inhibitors / toxicity*
-
Cholinesterase Reactivators / chemistry
-
Cholinesterase Reactivators / pharmacology*
-
Enzyme Activation / drug effects
-
Humans
-
In Vitro Techniques
-
Obidoxime Chloride / chemistry
-
Obidoxime Chloride / pharmacology
-
Organophosphates / toxicity*
-
Oximes / chemistry
-
Oximes / pharmacology*
-
Pralidoxime Compounds / chemistry
-
Pralidoxime Compounds / pharmacology
-
Pyridinium Compounds / chemistry
-
Pyridinium Compounds / pharmacology*
Substances
-
1,4-bis(4-hydroxyiminomethylpyridinium)butane dibromide
-
Butanes
-
Cholinesterase Inhibitors
-
Cholinesterase Reactivators
-
K075 compound
-
Organophosphates
-
Oximes
-
Pralidoxime Compounds
-
Pyridinium Compounds
-
Obidoxime Chloride
-
N,N'-monomethylenebis(pyridiniumaldoxime)
-
Acetylcholinesterase
-
asoxime chloride
-
pralidoxime
-
tabun